Day: August 7, 2020

HAUPPAUGE, N.Y., Aug. 07, 2020 (GLOBE NEWSWIRE) — United-Guardian, Inc. (NASDAQ:UG) reported today that net income for the second quarter of 2020 grew by 10% over the same quarter last year, increasing from $1,078,810 in 2019 to $1,186,611 this year, despite sales decreasing by 10% from $3,279,399 to $2,954,644. Sales for the first six months of the year were down slightly from $6,459,716 in 2019 to $6,277,558 this year, with net income for the six-month period decreasing from $2,301,504 ($0.50 a share) in 2019 to $1,976,918 ($0.43 a share) in the first six months of 2020.Ken Globus, President of United-Guardian, stated, “With many companies continuing to struggle during these difficult times, we were pleased that we were able to maintain a strong level of sales, even with some of our major markets, particularly China, being severely...

80% INCREASE IN NET BILLINGSRECORD SURGE IN NET BOOKINGSRESEARCH TRIANGLE PARK, NC, Aug. 07, 2020 (GLOBE NEWSWIRE) — Data443 Risk Mitigation, Inc. (“Data443” or the “Company”) (OTCPK: ATDS), a leading data security and privacy software company, today announced record operational and financial results for its second quarter (ended June 30, 2020), and for its first half of fiscal year 2020.Management CommentaryJason Remillard, CEO of Data443, commented, “Today’s results for the first half of 2020 truly highlights the strength of our team, the quality of our product offerings, and the priority positioning of our industry. Even in this challenging and unprecedented time of pandemic, we have proven that we continue to serve our clients and grow our business, highlighting the urgency and value of our technology offerings. Our name brand...

Oak Fund Services (Guernsey) LimitedCompany AdministratorAttn:  Mark WoodallTel:  +44 1481 723450                                                                                          Eurocastle Releases First Half 2020 Financial Results­Guernsey, 7 August 2020 – Eurocastle Investment Limited (Euronext Amsterdam: ECT) today has released its financial report for the six months ended 30 June 2020.Adjusted Net Asset Value (“NAV”) of €13.4 million1, or €7.26 per share2 up €0.48 per share vs. €6.78 per share at Q1 2020 (down €1.06 per share vs. €8.32 per share at Q4 2019) due to: Valuation movements:€0.19 per share increase (4%) in Q2 2020 (€1.43 per share decrease in H1 2020) on the remaining three real estate fund investments€0.05 per share increase (9%) in Q2 2020 (€0.03 per share decrease in H1 2020) on the remaining three NPL and other...

TORONTO, Aug. 07, 2020 (GLOBE NEWSWIRE) — Capstone Infrastructure Corporation (TSX: CSE.PR.A) (the “Corporation” or “Capstone”) today reports and filed its results for the second quarter ended June 30, 2020. The Corporation’s second quarter 2020 Management’s Discussion and Analysis (“MD&A”) and unaudited interim consolidated financial statements are available at www.capstoneinfrastructure.com and on SEDAR at www.sedar.com. Capstone’s MD&A details the “Results of Operations” and provides a “Financial Position Review” for the quarter ended June 30, 2020.Dividend DeclarationsThe board of directors today declared a quarterly dividend on the Corporation’s Cumulative Five-Year Rate Reset Preferred Shares, Series A (the “Preferred Shares”) of $0.2044 per Preferred...

Avis de réunion publié dans le BALO n° 95 le 07 août 2020Pièces jointesFIEBM BALOFIEBM BALO

Company Announcement No. 12/2020Copenhagen, 7 August 2020Attachment2012_Monthly update_July_2020_07_08_2020_UK

Selskabsmeddelelse nr. 12/2020København, 7. august 2020Vedhæftet fil2012_Maanedlig_opdatering_juli_2020_07_08_20_DK

– Biohaven will receive up to $250 million to fund zavegepant’s development in migraine and non-migraine indications– Royalty Pharma to acquire up to a 3% royalty for zavegepant, a 0.4% royalty of Nurtec™ ODT and success-based milestone payments– Royalty Pharma will purchase new Commercial Launch Preferred Equity from Biohaven for a total of $200 million payable between 2021 and 2024, providing additional funding for its CGRP-targeting franchiseNEW HAVEN, Conn.and NEW YORK, Aug. 07, 2020 (GLOBE NEWSWIRE) — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Royalty Pharma (Nasdaq: RPRX) announced today that Biohaven has secured up to $250 million in funding to advance the company’s CGRP receptor antagonist program through the development of zavegepant (formerly known as vazegepant). The zavegepant program...

ATHENS, Greece, Aug. 07, 2020 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Ausca Shipping Limited, Hong Kong, for one of its Panamax dry bulk vessels, the m/v Melia. The gross charter rate is US$10,000 per day, plus US$500,000 gross ballast bonus, minus a 5% commission paid to third parties, for a period of about eight (8) months to maximum ten (10) months. The charter is expected to commence on August 20, 2020.The “Melia” is a 76,225 dwt Panamax dry bulk vessel built in 2005.This employment is anticipated to generate approximately US$2.75 million of gross revenue for the minimum scheduled period of the time charter.Upon...

FRAMINGHAM, Mass., Aug. 07, 2020 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel liquid, gel and solid hemostatic and wound care devices, today announced updated presentation information for research from the AC5® self-assembling peptide technology platform being presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting. Because of the ongoing pandemic, the conference has been rescheduled to take place from August 11-13, 2020 and will be held virtually.The abstract has been accepted by SAGES, and the underlying research has been selected to be featured in a podium presentation during the Emerging Technology Session. The presentation, “Novel Self-assembling Agent, AC5-GTM, for Use in Submucosal Lifting in...